Scand J Infect Dis 2010 Apr;42(4):275-80
Department of Clinical Sciences, Lund University, Malmö, Swden.
Download full-text PDF
Scand J Infect Dis 2012 Aug 31;44(8):573-7. Epub 2012 Jan 31.
Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Background: Resistant Enterobacteriaceae have become a worldwide epidemic during the last decade and are a great threat to health care worldwide. International travel is a major risk factor for becoming colonized with extended-spectrum beta-lactamase (ESBL)-producing bacteria. Data on the persistence of colonization with ESBL-producing bacteria in the faecal flora are limited. Read More
Clin Microbiol Infect 2014 Oct 26;20(10):O636-9. Epub 2014 Mar 26.
Barcelona Centre for International Health Research, (CRESIB), (Hospital Clínic - University of Barcelona), Barcelona, Spain.
The aim of this study was to investigate the prevalence of extended-spectrum β-lactamase (ESBL) -producing Escherichia coli in stool samples from 457 patients with travellers' diarrhoea who had travelled to tropical and subtropical countries. Ninety-seven ESBL-producing E. coli strains were isolated from 17. Read More
J Med Microbiol 2013 Jul 28;62(Pt 7):1038-43. Epub 2013 Mar 28.
Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, 812-8582, Japan.
Community-acquired infections caused by extended-spectrum β-lactamase (ESBL)-producing bacteria, particularly CTX-M-producing Escherichia coli, are a rising concern worldwide. There are few data from Japan on the acquisition of ESBLs in the community or the influx of these bacteria into hospitals. Therefore, we examined the prevalence of ESBL carriage in outpatients, in order to estimate the spread of ESBLs in community settings. Read More
J Microbiol Immunol Infect 2012 Jun 12;45(3):193-9. Epub 2012 May 12.
Division of Infectious Diseases, Department of Internal Medicine, Cathay General Hospital, Taipei City, Taiwan.
Background: Extended-spectrum β-lactamase (ESBL)-producing bacteria coexpressing AmpC type β-lactamase (ACBL) are associated with the laboratory issue of false susceptibility to third-generation cephalosporins. This study was to evaluate laboratory tests and clinical significance of bacteremic isolates of Escherichia coli and Klebsiella pneumoniae with both ESBL and ACBL [dual-type lactamases (DTL)].
Methods: From 2006 to 2009, 78 E coli and 12 pneumoniae bacteremic isolates with reduced susceptibility to cefotaxime (CTX) or ceftazidime (CAZ) were identified and relevant patients' data were collected for analysis. Read More